CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Regentis Biomaterials is focused on developing and commercializing hydrogels for tissue regeneration. The Gelrin hydrogel platform is a matrix of polyethylene glycol diacrylate (PEG-DA) and denatured fibrinogen, combining the stability and versatilit...Show all
Company (Alive / Active)
Phone: +972-4-6265502
Northern Industrial Zone
12 Ha’ilan Street
Or Akiva, 3060000
Israel
| Total Funding | Date of Last Funding | |
|---|---|---|
| Regentis Biomaterials | $32.5M | Jan 9, 2019 |
| BioMimetic Therapeutics | $92M | Mar 2, 2013 |
| The DNA Repair Company | $0M | Oct 10, 2019 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Treatment of cavities in a human body | Oct 06, 2014 | Feb 20, 2018 | Patent |
| Treatment of cavities in a human body | Apr 06, 2015 | Jan 23, 2018 | Patent |
| Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same | Aug 31, 2015 | Jul 11, 2017 | Patent |
| Compositions and methods for scaffold formation | Apr 16, 2008 | Apr 18, 2017 | Patent |
| Pegylated fibrinogen precursor molecule | Oct 13, 2014 | Oct 25, 2016 | Patent |
